Brief: Summit Is Considering A $15 Billion Partnership With AstraZeneca - Bloomberg News
03/07/2025 15:29
July 3 (Reuters) - SUMMIT IS CONSIDERING A $15 BILLION PARTNERSHIP WITH ASTRAZENECA - BLOOMBERG NEWS Source text: [https://tinyurl.com/bdzjwy4y] Further company coverage: AZN.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
Brief: Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Factbox: Major drugmakers turn to China for licensing deals
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)